# catalytic_activity_0077

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `catalytic_activity`  
**Author expected answer:** **A** — 12-deshydroxyl okaramine E + 2 reduced &#91;NADPH--hemoprotein reductase&#93; + 2 O2 = 3-desmethyl okaramine B + 2 oxidized &#91;NADPH--hemoprotein reductase&#93; + 2 H2O + 2 H(+)

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | supported | lookup-dependent | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | valid_review |

**Paired comparison:** key agree; reasoning differ. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
MSLISPLAAVLSAMAIVLGLLFFPNMTPQPTLHPRVGWRKEKASTLRAALRSCYKLNDWALEGYNAYAKLNIPYVLPSFDRGPITIIPARLMRRLYTLPDTDLDIRMTQQETNQTRWVAWDKKPAEDTFVWDVLRKQITRNLRQLTPIVASEIELSFNRWWGTDKEWKSIDIWDSCWKIVTGGINTTLCGSPLCRDAEFLQSCQNHSLVLVAGAMAINGAPRLLQPIIGGLVWFVCAILFNTTMKRSKAVVQERLEKTAMLRAEPAYDWKPPQDAIQWIIDDLYASDNLTQLNVKTICFRLLLLNDVSIPSTSFSVQTLLLNLFAADPALGFLEALREECQTVYTESGGVWTYDALKKLKITESAIRESLRLSPVGGIGLHRTVVNPKGISLPDYRLNLPHGTVIASPIESIHYDDDIYPHANDYNAFRFADPEAVRAILDKLSSEPNSNISTGGPRDRESKSAASTANIDEAFLAFGIGKHICPGRFFVMVEMKLILAIILVHYDVKPVKFKPKLVDCLWLKVPWNSGTLVVRRRSN

[Multiple Choices]
A. 12-deshydroxyl okaramine E + 2 reduced [NADPH--hemoprotein reductase] + 2 O2 = 3-desmethyl okaramine B + 2 oxidized [NADPH--hemoprotein reductase] + 2 H2O + 2 H(+)
B. hypoxanthine(out) = hypoxanthine(in)
C. restrictinol + glycine + H(+) = restricticin + H2O
D. cytidine(34) in elongator tRNA(Met) + acetyl-CoA + ATP + H2O = N(4)-acetylcytidine(34) in elongator tRNA(Met) + ADP + phosphate + CoA + H(+)
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Enzymatic Reaction Prediction, which is to identify the specific chemical reaction catalyzed by a given enzyme. This involves understanding the enzyme's function based on its amino acid sequence and then selecting the correct transformation of substrates into products from a list of possible reactions.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The exact sequence matches the UniProt record annotated with choice A as its catalytic activity. That annotation cites experimental evidence (ECO:0000269) and PubMed:28631282; the historical record also matches the sequence.

Citations as saved: [C1](#evidence-c1), [C5](#evidence-c5), [H4](#evidence-h4).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence has features consistent with a membrane-associated cytochrome P450, which makes an oxygen- and reductase-dependent oxidation plausible and distinguishes it broadly from the transport and acetylation choices.


**Missing item-specific fact**

> The sequence features alone do not identify the specific okaramine substrate and product in choice A; that substrate specificity requires a protein-specific annotation or experimental result.


**Reason**

> The family-level clue supports an oxidative enzyme, but the question asks for an exact chemical transformation. Selecting the particular okaramine reaction depends on item-specific functional knowledge not supplied in the input.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The supplied evidence supports choice A, and the alternatives describe distinct transport or enzyme activities.


### Important caveats

- The UniProt annotation reports experimental evidence and cites PubMed:28631282, but the primary paper was not independently retrieved or validated here.
- The reviewer-only sequence match and annotation were not available to the evaluated model.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence has features consistent with a membrane-associated cytochrome P450, which makes an oxygen- and reductase-dependent oxidation plausible and distinguishes it broadly from the transport and acetylation choices.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The sequence features alone do not identify the specific okaramine substrate and product in choice A; that substrate specificity requires a protein-specific annotation or experimental result.",
    "reason": "The family-level clue supports an oxidative enzyme, but the question asks for an exact chemical transformation. Selecting the particular okaramine reaction depends on item-specific functional knowledge not supplied in the input."
  },
  "case_id": "catalytic_activity_0077",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C5",
      "H4"
    ],
    "judgment": "supported",
    "reason": "The exact sequence matches the UniProt record annotated with choice A as its catalytic activity. That annotation cites experimental evidence (ECO:0000269) and PubMed:28631282; the historical record also matches the sequence."
  },
  "important_caveats": [
    "The UniProt annotation reports experimental evidence and cites PubMed:28631282, but the primary paper was not independently retrieved or validated here.",
    "The reviewer-only sequence match and annotation were not available to the evaluated model."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The supplied evidence supports choice A, and the alternatives describe distinct transport or enzyme activities."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "catalytic_activity_0077",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact sequence matches the UniProt record annotated with choice A as its catalytic activity. That annotation cites experimental evidence (ECO:0000269) and PubMed:28631282; the historical record also matches the sequence.",
    "evidence_ids": ["C1", "C5", "H4"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence has features consistent with a membrane-associated cytochrome P450, which makes an oxygen- and reductase-dependent oxidation plausible and distinguishes it broadly from the transport and acetylation choices.",
    "missing_item_specific_fact": "The sequence features alone do not identify the specific okaramine substrate and product in choice A; that substrate specificity requires a protein-specific annotation or experimental result.",
    "reason": "The family-level clue supports an oxidative enzyme, but the question asks for an exact chemical transformation. Selecting the particular okaramine reaction depends on item-specific functional knowledge not supplied in the input."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The supplied evidence supports choice A, and the alternatives describe distinct transport or enzyme activities."
  },
  "important_caveats": [
    "The UniProt annotation reports experimental evidence and cites PubMed:28631282, but the primary paper was not independently retrieved or validated here.",
    "The reviewer-only sequence match and annotation were not available to the evaluated model."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry A0A2Z5U3C2 (OKAG_PENOH) for the matched 538-aa sequence explicitly annotates the catalytic activity as '12-deshydroxyl okaramine E + 2 reduced &#91;NADPH--hemoprotein reductase&#93; + 2 O2 = 3-desmethyl okaramine B + 2 oxidized &#91;NADPH--hemoprotein reductase&#93; + 2 H2O + 2 H(+)', with evidence code ECO:0000269 (direct assay) from PubMed:28631282. This exactly matches Choice A.

Citations as saved: [C5](#evidence-c5), [H4](#evidence-h4), [C4](#evidence-c4), [H2](#evidence-h2).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence contains the canonical P450 heme-binding motif FxxGxxxCxG (visible as 'FGIGKHICPGR' near the C-terminus), identifying the protein as a cytochrome P450 monooxygenase. Among the four choices, only A describes a P450-type reaction (consuming O2 and reduced NADPH-hemoprotein reductase). Choice B is a simple membrane transport reaction, C is a non-ribosomal peptide synthetase condensation, and D is a tRNA acetyltransferase reaction—none of which involve P450 chemistry. The heme-binding motif thus provides a concrete, sequence-identifiable feature that meaningfully eliminates B, C, and D.


**Missing item-specific fact**

> The exact substrate/product names (12-deshydroxyl okaramine E → 3-desmethyl okaramine B) are specific to okaG and cannot be deduced from sequence alone; however, they are not needed to select A over the other three options, which are incompatible with P450 chemistry.


**Reason**

> The P450 heme-binding motif is a well-known, recognizable sequence signature. A model with general knowledge of enzyme classes can identify this motif and match it to the only P450-compatible reaction among the choices. The specific okaramine substrate names are lookup-dependent but not required to discriminate A from B/C/D.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Choices B, C, and D describe fundamentally different enzyme classes (transporter, NRPS, acetyltransferase) that are incompatible with the P450 heme-binding motif present in the sequence. Only A involves P450 monooxygenase chemistry. No other option is defensible given the sequence evidence.


### Important caveats

- The specific okaramine substrate/product names in Choice A are lookup-dependent; a model could select A on P450-class grounds without knowing the exact substrates.
- The P450 heme-binding motif (FGIGKHICPGR) is present but the full P450 domain architecture should be verified computationally for robustness.
- The UniProt annotation carries ECO:0000269 (direct assay) evidence from a 2017 Angew. Chem. paper, indicating experimental validation of this specific reaction.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains the canonical P450 heme-binding motif FxxGxxxCxG (visible as 'FGIGKHICPGR' near the C-terminus), identifying the protein as a cytochrome P450 monooxygenase. Among the four choices, only A describes a P450-type reaction (consuming O2 and reduced NADPH-hemoprotein reductase). Choice B is a simple membrane transport reaction, C is a non-ribosomal peptide synthetase condensation, and D is a tRNA acetyltransferase reaction—none of which involve P450 chemistry. The heme-binding motif thus provides a concrete, sequence-identifiable feature that meaningfully eliminates B, C, and D.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "The exact substrate/product names (12-deshydroxyl okaramine E → 3-desmethyl okaramine B) are specific to okaG and cannot be deduced from sequence alone; however, they are not needed to select A over the other three options, which are incompatible with P450 chemistry.",
    "reason": "The P450 heme-binding motif is a well-known, recognizable sequence signature. A model with general knowledge of enzyme classes can identify this motif and match it to the only P450-compatible reaction among the choices. The specific okaramine substrate names are lookup-dependent but not required to discriminate A from B/C/D."
  },
  "case_id": "catalytic_activity_0077",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H4",
      "C4",
      "H2"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry A0A2Z5U3C2 (OKAG_PENOH) for the matched 538-aa sequence explicitly annotates the catalytic activity as '12-deshydroxyl okaramine E + 2 reduced [NADPH--hemoprotein reductase] + 2 O2 = 3-desmethyl okaramine B + 2 oxidized [NADPH--hemoprotein reductase] + 2 H2O + 2 H(+)', with evidence code ECO:0000269 (direct assay) from PubMed:28631282. This exactly matches Choice A."
  },
  "important_caveats": [
    "The specific okaramine substrate/product names in Choice A are lookup-dependent; a model could select A on P450-class grounds without knowing the exact substrates.",
    "The P450 heme-binding motif (FGIGKHICPGR) is present but the full P450 domain architecture should be verified computationally for robustness.",
    "The UniProt annotation carries ECO:0000269 (direct assay) evidence from a 2017 Angew. Chem. paper, indicating experimental validation of this specific reaction."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Choices B, C, and D describe fundamentally different enzyme classes (transporter, NRPS, acetyltransferase) that are incompatible with the P450 heme-binding motif present in the sequence. Only A involves P450 monooxygenase chemistry. No other option is defensible given the sequence evidence."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "catalytic_activity_0077",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry A0A2Z5U3C2 (OKAG_PENOH) for the matched 538-aa sequence explicitly annotates the catalytic activity as '12-deshydroxyl okaramine E + 2 reduced [NADPH--hemoprotein reductase] + 2 O2 = 3-desmethyl okaramine B + 2 oxidized [NADPH--hemoprotein reductase] + 2 H2O + 2 H(+)', with evidence code ECO:0000269 (direct assay) from PubMed:28631282. This exactly matches Choice A.",
    "evidence_ids": ["C5", "H4", "C4", "H2"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence contains the canonical P450 heme-binding motif FxxGxxxCxG (visible as 'FGIGKHICPGR' near the C-terminus), identifying the protein as a cytochrome P450 monooxygenase. Among the four choices, only A describes a P450-type reaction (consuming O2 and reduced NADPH-hemoprotein reductase). Choice B is a simple membrane transport reaction, C is a non-ribosomal peptide synthetase condensation, and D is a tRNA acetyltransferase reaction—none of which involve P450 chemistry. The heme-binding motif thus provides a concrete, sequence-identifiable feature that meaningfully eliminates B, C, and D.",
    "missing_item_specific_fact": "The exact substrate/product names (12-deshydroxyl okaramine E → 3-desmethyl okaramine B) are specific to okaG and cannot be deduced from sequence alone; however, they are not needed to select A over the other three options, which are incompatible with P450 chemistry.",
    "reason": "The P450 heme-binding motif is a well-known, recognizable sequence signature. A model with general knowledge of enzyme classes can identify this motif and match it to the only P450-compatible reaction among the choices. The specific okaramine substrate names are lookup-dependent but not required to discriminate A from B/C/D."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Choices B, C, and D describe fundamentally different enzyme classes (transporter, NRPS, acetyltransferase) that are incompatible with the P450 heme-binding motif present in the sequence. Only A involves P450 monooxygenase chemistry. No other option is defensible given the sequence evidence."
  },
  "important_caveats": [
    "The specific okaramine substrate/product names in Choice A are lookup-dependent; a model could select A on P450-class grounds without knowing the exact substrates.",
    "The P450 heme-binding motif (FGIGKHICPGR) is present but the full P450 domain architecture should be verified computationally for robustness.",
    "The UniProt annotation carries ECO:0000269 (direct assay) evidence from a 2017 Angew. Chem. paper, indicating experimental validation of this specific reaction."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `A0A2Z5U3C2` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 23. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A2Z5U3C2.json)  
**Locator:** `/primaryAccession`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-01T06:24:45.085132+00:00.  

```json
"A0A2Z5U3C2"
```

Source SHA-256: `454d6675d7f29be183ee37db1d84418a9764ea66363a58cfbd2c8097f7b0039e`.

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A2Z5U3C2.json)  
**Locator:** `/proteinDescription`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-01T06:24:45.085132+00:00.  

```json
{"alternativeNames":[{"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"28631282","source":"PubMed"}],"value":"Okaramines biosynthesis cluster protein G"}}],"recommendedName":{"ecNumbers":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"28631282","source":"PubMed"}],"value":"1.14.14.-"}],"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"28631282","source":"PubMed"}],"value":"Cytochrome P450 monooxygenase okaG"}}}
```

Source SHA-256: `454d6675d7f29be183ee37db1d84418a9764ea66363a58cfbd2c8097f7b0039e`.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A2Z5U3C2.json)  
**Locator:** `/comments/1`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-01T06:24:45.085132+00:00.  

```json
{"commentType":"CATALYTIC ACTIVITY","physiologicalReactions":[{"directionType":"left-to-right","evidences":[{"evidenceCode":"ECO:0000269","id":"28631282","source":"PubMed"}],"reactionCrossReference":{"database":"Rhea","id":"RHEA:82712"}}],"reaction":{"evidences":[{"evidenceCode":"ECO:0000269","id":"28631282","source":"PubMed"}],"name":"12-deshydroxyl okaramine E + 2 reduced [NADPH--hemoprotein reductase] + 2 O2 = 3-desmethyl okaramine B + 2 oxidized [NADPH--hemoprotein reductase] + 2 H2O + 2 H(+)","reactionCrossReferences":[{"database":"Rhea","id":"RHEA:82711"},{"database":"Rhea","id":"RHEA-COMP:11964"},{"database":"Rhea","id":"RHEA-COMP:11965"},{"database":"ChEBI","id":"CHEBI:15377"},{"database":"ChEBI","id":"CHEBI:15378"},{"database":"ChEBI","id":"CHEBI:15379"},{"database":"ChEBI","id":"CHEBI:57618"},{"database":"ChEBI","id":"CHEBI:58210"},{"database":"ChEBI","id":"CHEBI:232466"},{"database":"ChEBI","id":"CHEBI:232467"}]}}
```

Source SHA-256: `454d6675d7f29be183ee37db1d84418a9764ea66363a58cfbd2c8097f7b0039e`.

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A2Z5U3C2?format=txt&versions=23)  
**Locator:** `lines 6-8`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 23 / 1.  
**Retrieved:** 2026-11-01T06:27:27.781901+00:00.  

```text
DE   RecName: Full=Cytochrome P450 monooxygenase okaG {ECO:0000303|PubMed:28631282};
DE            EC=1.14.14.- {ECO:0000269|PubMed:28631282};
DE   AltName: Full=Okaramines biosynthesis cluster protein G {ECO:0000303|PubMed:28631282};
```

Source SHA-256: `1698803cc414279a9333d82041e912b681b2e52dab9e77c6babce8f882640894`.

### Evidence H4

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A2Z5U3C2?format=txt&versions=23)  
**Locator:** `lines 61-70`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 23 / 1.  
**Retrieved:** 2026-11-01T06:27:27.781901+00:00.  

```text
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=12-deshydroxyl okaramine E + 2 reduced [NADPH--hemoprotein
CC         reductase] + 2 O2 = 3-desmethyl okaramine B + 2 oxidized [NADPH--
CC         hemoprotein reductase] + 2 H2O + 2 H(+); Xref=Rhea:RHEA:82711,
CC         Rhea:RHEA-COMP:11964, Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:57618,
CC         ChEBI:CHEBI:58210, ChEBI:CHEBI:232466, ChEBI:CHEBI:232467;
CC         Evidence={ECO:0000269|PubMed:28631282};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:82712;
CC         Evidence={ECO:0000269|PubMed:28631282};
```

Source SHA-256: `1698803cc414279a9333d82041e912b681b2e52dab9e77c6babce8f882640894`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/catalytic_activity.json), zero-based source row 77. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
